CRISPR

R&D roundup: the ups and downs of CRISPR and Alzheimer’s

https://pharmaphorum.com/r-d/views-analysis-r-d/rd-roundup-the-ups-and-downs-of-crispr-and-alzheimers/

CRISPR gene editing stocks fall after Editas CEO resigns

https://pharmaphorum.com/news/crispr-gene-editing-stocks-fall-after-editas-ceo-resigns/

2018 in review: Alzheimer’s falters while oncology shines

https://pharmaphorum.com/r-d/views-analysis-r-d/2018-review-alzheimers-research-oncology/

AZ and CRUK team up to go all-in on CRISPR

https://pharmaphorum.com/news/az-cruk-crispr/

Explore the latest developments in ATMPs at Cell & Gene Therapy 2018

https://pharmaphorum.com/partner-content/explore-the-latest-developments-in-atmps-at-cell-gene-therapy-2018-3/

Your Exclusive Invitation from the Chair for Cell & Gene Therapy 2018

https://pharmaphorum.com/partner-content/your-exclusive-invitation-from-the-chair-for-cell-gene-therapy-2018/

CRISPR Congress Europe 2018 | Genome Evolution Conference‎

https://pharmaphorum.com/events/crispr-congress-europe-2018-genome-evolution-conference%e2%80%8e/

Complex Co-Cultured Spheroids to Validate Tumour Models in Microfluidic Devices

https://pharmaphorum.com/partner-content-oncology/complex-co-cultured-spheroids-validate-tumour-models-microfluidic-devices/

3D Cell Culture 2018: Exclusive New Interviews Released

https://pharmaphorum.com/partner-content/3d-cell-culture-2018-exclusive-new-interviews-released/

1 2 3

Close in 10 seconds

Pharmaphorum.com

Search